TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
RMD

ResMed Inc

Healthcare · Medical Instruments & Supplies

223.60$ -0.6% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow RMD
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
22.8% 29.8% 20.0% 21.6% 17.6% 27.1% 23.0% 9.8% 16.4% 29.9% 34.0% 31.9%
4.4% 4.7% 5.4% 5.1% 5.8% 6.1% 6.0% 5.4% 4.7% 4.6% 4.6% 4.3%
2.9% 2.5% 2.2% 2.1% 2.0% 1.9% 2.0% 1.8% 1.7% 1.7% 1.8% 1.8%
1.3% 2.6% 2.8% 2.6% 3.1% 2.8% 2.2% 2.4% 1.4%
-3.9% 3.4% -4.3% 0.4% -6.8% -3.3% 0.0% -19.8% -10.9% 1.0% 0.3% -1.3%
4.3% 3.7% 3.5% 3.1% 3.0% 3.6% 3.7% 4.4% 3.2% 2.5% 1.7% 2.8%
-8.5% -61.2% -4.0% -4.4% -41.3% -6.1% -5.0% -6.4% -27.5% -5.8% -3.9% -9.6%
9.4% 9.1% 9.0% 8.5% 8.1% 7.6% 7.1% 6.9% 6.1% 6.0% 6.0% 6.2%
-9.5% -5.6% -4.9% -2.3% -0.9% 40.2% 2.8% 1.3% 25.3% -3.2% -5.8% -12.4%
-0.1% 46.6% -4.6% -34.0% 31.0% -3.2% -16.3% 3.4% 15.7% -15.6% -0.8% -0.2%
-15.2% 33.3% -12.7% -43.9% 22.3% -10.7% -23.9% -3.6% 10.0% -23.9% -11.8% -17.8%
-11.2% 0.8% 4.4% -27.1% -1.6% 10.7% -5.3% -0.6% -1.1% 0.2% 18.9% 4.6%
18.5% 26.1% 16.6% 18.5% 14.6% 23.5% 19.4% 5.5% 13.2% 27.5% 32.3% 29.2%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?